BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 866 filers reported holding BAXTER INTL INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $1,282,200 | -66.8% | 30,000 | -70.0% | 0.22% | -63.4% |
Q4 2023 | $3,866,000 | -77.5% | 100,000 | -51.3% | 0.59% | -61.0% |
Q4 2019 | $17,184,000 | +227.4% | 205,500 | +242.5% | 1.51% | +68.8% |
Q3 2019 | $5,248,000 | +70.9% | 60,000 | +60.0% | 0.90% | +92.3% |
Q2 2019 | $3,071,000 | -46.0% | 37,500 | -46.4% | 0.47% | -42.4% |
Q1 2019 | $5,692,000 | +35.1% | 70,000 | +9.4% | 0.81% | -3.8% |
Q4 2018 | $4,212,000 | -8.9% | 64,000 | +6.7% | 0.84% | -13.6% |
Q3 2018 | $4,625,000 | +56.6% | 60,000 | +50.0% | 0.97% | -17.8% |
Q2 2018 | $2,954,000 | -39.4% | 40,000 | -46.7% | 1.18% | -58.9% |
Q1 2018 | $4,878,000 | +7.8% | 75,000 | +7.1% | 2.88% | +52.2% |
Q4 2017 | $4,525,000 | -73.3% | 70,000 | -74.1% | 1.89% | -61.8% |
Q3 2017 | $16,942,000 | +123.9% | 270,000 | +116.0% | 4.96% | +65.0% |
Q2 2017 | $7,568,000 | -18.9% | 125,000 | -30.6% | 3.00% | +8.8% |
Q1 2017 | $9,335,000 | +40.4% | 180,000 | +20.0% | 2.76% | +13.2% |
Q4 2016 | $6,651,000 | -12.7% | 150,000 | -6.2% | 2.44% | +5.4% |
Q3 2016 | $7,616,000 | +14.3% | 160,000 | +8.6% | 2.31% | -18.3% |
Q2 2016 | $6,661,000 | +4.6% | 147,305 | -5.0% | 2.83% | -2.2% |
Q1 2016 | $6,367,000 | -44.4% | 155,000 | -48.3% | 2.90% | -40.1% |
Q4 2015 | $11,445,000 | -57.7% | 300,000 | -24.1% | 4.83% | -65.4% |
Q1 2015 | $27,058,000 | +427.4% | 395,000 | +464.3% | 13.96% | +639.9% |
Q4 2014 | $5,130,000 | – | 70,000 | – | 1.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |